Abstract:Hepatocellular carcinoma (HCC) is a typical hypervascular tumor, and increased levels of vascular endothelial growth factor (VEGF) are associated with progression of HCC. Tumor suppression gene PTEN (phosphatase and tensin homolog deleted on chromosome 10), an important antagonist of the phosphoinositide-3-kinase (PI3K)/adenosine triphosphate-dependent tyrosine kinase (Akt) pathway, is also commonly lost or mutated in HCC. However, the effect of PTEN on VEGF-mediated angiogenesis in HCC remains unknown. To explore this relationship, we expressed a panel of PTEN mutants in human HCC cells with low expression of PTEN (HepG2 cells). Overexpression of PTEN in HepG2 cells resulted in the downregulation of proliferation and migration of cocultured endothelial cells and decreased expression of hypoxia-inducible factor 1 (HIF-1) and VEGF. Similarly, using a nude mouse model, we demonstrated that PTEN decreased expression of HIF-1 and VEGF and suppressed HepG2-induced angiogenesis. This inhibitory effect was not observed in cells expressing a phosphatase-deficient PTEN mutant, suggesting that PTEN inhibits angiogenesis and VEGF through a phosphatase-dependent pathway. Strikingly, reintroducing the C2 domain of PTEN also resulted in a significant decrease in angiogenesis and VEGF expression, although it did not affect Akt phosphorylation or HIF-1 expression. In summary, this study suggests the novel viewpoint that PTEN suppresses angiogenesis and VEGF expression in HCC through both phosphatase-dependent and -independent mechanisms.

PTEN-L promotes type I interferon responses and antiviral immunity

The tumor suppressor PTEN has a critical role in antiviral innate immunity

The functions of tumor suppressor PTEN in innate and adaptive immunity

PTENα functions as an immune suppressor and promotes immune resistance in PTEN-mutant cancer

PTEN Directs Developmental and Metabolic Signaling for Innate-Like T Cell Fate and Tissue Homeostasis.

Secreted PTEN binds PLXDC2 on macrophages to drive antitumor immunity and tumor suppression

New Insights into PTEN Regulation Mechanisms and Its Potential Function in Targeted Therapies.

Decoding PTEN: from biological functions to signaling pathways in tumors

PTENε Suppresses Tumor Metastasis Through Regulation of Filopodia Formation.

The PTEN tumor suppressor gene and its role in lymphoma pathogenesis

The regulation of PTEN: Novel insights into functions as cancer biomarkers and therapeutic targets

Regulation of the tumor suppressor PTEN by natural anticancer compounds

The Phosphatase PTEN Links Platelets with Immune Regulatory Functions of Mouse T Follicular Helper Cells.

RNA-binding protein PTENα blocks RIG-I activation to prevent viral inflammation

Preparation and characterization of a polyclonal antibody against PTEN-Long

The functions and regulation of the PTEN tumour suppressor: new modes and prospects

PTEN Dual Lipid- and Protein-Phosphatase Function in Tumor Progression

PTEN acts as a crucial inflammatory checkpoint controlling TLR9/IL-6 axis in B cells

Myeloid PTEN Promotes Chemotherapy-Induced NLRP3-inflammasome Activation and Antitumour Immunity

Regulatory Mechanisms of PTEN

PTEN Regulates Angiogenesis and VEGF Expression Through Phosphatase-Dependent and -Independent Mechanisms in HepG2 Cells